Author

D. V. Shcheblyakov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

A. L. Gintsburg· 2 shared D. V. Voronina· 2 shared I. A. Favorskaya· 2 shared I. B. Esmagambetov· 2 shared A. A. Derkaev· 1 shared A. A. Iliukhina· 1 shared A. G. Botikov· 1 shared A. I. Korobkova· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. L. Gintsburg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 29, 2022

Cross-reactive single-domain antibodies to hemagglutinin stem region protect mice from group 1 influenza A virus infection

D. V. Voronina, A. S. Bandelyuk, A. S. Dzharullaeva…·A. L. Gintsburg

This study modifies two single-domain antibodies to enhance their neutralizing activity against multiple influenza A virus subtypes and demonstrates their protective efficacy in mice.

DOI 10.1101/2022.09.29.510074

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 24, 2021

Single-domain antibodies efficiently neutralize SARS-CoV-2 variants of concern, including Omicron variant

I. A. Favorskaya, D. V. Shcheblyakov, I. B. Esmagambetov…·A. L. Gintsburg

The paper identifies single-domain antibodies that neutralize SARS-CoV-2 variants, including Omicron, with enhanced potency through dimeric modifications.

DOI 10.1101/2021.11.24.469842

experimental assayhost-pathogen & immune response

𝕏 PostBluesky